Massmutual Trust CO Fsb Biogen Inc. Transaction History

Massmutual Trust CO Fsb

$3.48 Billion
Q3 2024

A detailed history of Massmutual Trust CO Fsb transactions in Biogen Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 376 shares of BIIB stock, worth $59,674. This represents 0.0% of its overall portfolio holdings.

Number of Shares

376

Previous 494 23.89%

Holding current value

$59,674

Previous $114,000 36.84%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 02, 2024	SELL	$189.07 - $236.8 $22,310 - $27,942	-118 Reduced 23.89%	376 $72,000
Q2 2024 Jul 02, 2024	BUY	$190.52 - $236.72 $30,673 - $38,111	161 Added 48.35%	494 $114,000
Q1 2024 Apr 09, 2024	BUY	$212.02 - $267.71 $19,505 - $24,629	92 Added 38.17%	333 $71,000
Q4 2023 Jan 03, 2024	BUY	$222.59 - $267.94 $2,225 - $2,679	10 Added 4.33%	241 $62,000
Q3 2023 Oct 03, 2023	SELL	$253.3 - $285.89 $5,825 - $6,575	-23 Reduced 9.06%	231 $59,000
Q2 2023 Aug 01, 2023	BUY	$275.25 - $318.06 $14,863 - $17,175	54 Added 27.0%	254 $72,000
Q1 2023 Apr 11, 2023	BUY	$256.56 - $292.34 $21,551 - $24,556	84 Added 72.41%	200 $55,000
Q4 2022 Jan 06, 2023	BUY	$252.44 - $306.72 $2,019 - $2,453	8 Added 7.41%	116 $32,000
Q3 2022 Oct 07, 2022	BUY	$194.69 - $268.46 $4,672 - $6,443	24 Added 28.57%	108 $29,000
Q2 2022 Jul 07, 2022	BUY	$187.54 - $223.02 $2,062 - $2,453	11 Added 15.07%	84 $17,000
Q1 2022 Apr 08, 2022	BUY	$193.77 - $244.14 $10,657 - $13,427	55 Added 305.56%	73 $15,000
Q4 2021 Feb 09, 2022	SELL	$223.92 - $287.77 $7,165 - $9,208	-32 Reduced 64.0%	18 $4,000
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $3.11 Million - $4.06 Million	-10,998 Reduced 99.55%	50 $14,000
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $58,793 - $94,139	-227 Reduced 2.01%	11,048 $3.83 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $62,195 - $72,865	256 Added 2.32%	11,275 $3.15 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $213,106 - $320,778	-902 Reduced 7.57%	11,019 $2.7 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $41,568 - $47,996	-157 Reduced 1.3%	11,921 $3.38 Million
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $130,105 - $172,302	503 Added 4.35%	12,078 $3.23 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $29,304 - $37,173	-109 Reduced 0.93%	11,575 $3.66 Million
Q4 2019 May 15, 2020	SELL	$220.06 - $304.07 $17,164 - $23,717	-78 Reduced 0.66%	11,684 $3.47 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $179,605 - $201,444	-826 Reduced 6.56%	11,762 $2.74 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $326,084 - $359,437	-1,487 Reduced 10.56%	12,588 $2.94 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $63,062 - $98,637	291 Added 2.11%	14,075 $3.33 Billion
Q4 2018 Feb 26, 2019	BUY	$278.5 - $352.75 $40,104 - $50,796	144 Added 1.06%	13,784 $4.15 Billion
Q3 2018 Nov 09, 2018	SELL	$293.51 - $383.83 $349,570 - $457,141	-1,191 Reduced 8.03%	13,640 $4.82 Billion
Q2 2018 Aug 20, 2018	BUY	$257.52 - $306.91 $360,528 - $429,674	1,400 Added 10.42%	14,831 $4.3 Billion
Q1 2018 May 21, 2018	BUY	$260.13 - $367.91 $188,854 - $267,102	726 Added 5.71%	13,431 $3.68 Billion
Q4 2017 Mar 01, 2018	SELL	$307.64 - $344.58 $16.8 Million - $18.8 Million	-54,540 Reduced 81.11%	12,705 $4.05 Billion
Q4 2017 Feb 21, 2018	BUY	$307.64 - $344.58 $17.3 Million - $19.3 Million	56,114 Added 504.12%	67,245 $4.31 Billion
Q3 2017 Feb 13, 2018	BUY	$281.15 - $329.69 $53,980 - $63,300	192 Added 1.76%	11,131 $3.49 Billion
Q2 2017 Aug 14, 2017	BUY	N/A	10,939	10,939 $2.97 Billion

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.

Account

Massmutual Trust CO Fsb Biogen Inc. Transaction History